fashion -WSS

fashion

author：hotspot 2025-10-02 22:40:58 - browse：88

Scientists Christina Frey and Paul Negulescu work in a lab at Vertex Pharmaceuticals. -- biotech coverage from STAT — Scientists Christina Frey and Paul Negulescu work in a lab at Vertex Pharmaceuticals in San Diego. Sandy Huffaker for STAT

A pain relief drug developed by Vertex Pharmaceuticals succeeded in late-stage clinical trials, the company announced Tuesday, bringing the biopharma giant a step closer to launching what observers believe could be a potential blockbuster and upending decades of pharma failure in a complicated field.

In a pair of randomized, placebo-controlled Phase 3 trials for patients with pain after a tummy tuck or bunion surgery, the drug showed statistically significant pain reduction compared to placebo, meeting the primary endpoints for these studies and the expectations of market analysts. But the experimental therapy didn’t relieve pain better than a combination of acetaminophen and the opioid hydrocodone, a key secondary endpoint observers had been waiting on. And in the bunionectomy trial, the opioid comparator outperformed VX-548 at soothing pain.

The drug, a small molecule known as VX-548, blocks pain-sensing neurons from signaling the pain without the addictive potential of opioids. It was generally safe, with fewer patients on VX-548 reporting adverse events than those taking the placebo.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Why health workers in Gaza are injured or die at high rates

entertainment

WSS

FDA warns J&J's Abiomed: We will regulate your software

FDA struggles to regulate food additives, sometimes for decades

CEOs share strategies for surviving biotech slump

Beam Therapeutics to lay off 20% of its staff, re

Eli Lilly to acquire Versanis in heated race for weight loss drugs

STAT Readout Newsletter: Today's biggest biotech updates

focus

fashion

hotspot

Virginia high school admissions case could be legal follow

Georgia court denies Trump's request to quash DA's 2020 election probe

Psychedelics group wrestles with new pharma identity

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

Tori Bowie and the unacceptable rates of Black maternal death

How climate

Apple is now the first public company to be valued at $3 trillion

Senate committee scrutinizes Medicare Advantage brokers

Dobbs anniversary: the lost opportunity of abortion as health care

UnitedHealth’s board chair also owns a personal investment firm

focus

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

UnitedHealth’s board chair also owns a personal investment firm

CEOs share strategies for surviving biotech slump

Beam Therapeutics to lay off 20% of its staff, re

Senate committee scrutinizes Medicare Advantage brokers

HHS leader on health, climate change and biopharma emissions

leisure time

entertainment

knowledge

explore